AcuTect Phase IV Study Will Examine Utility Of Negative Thrombosis Scans
This article was originally published in The Gray Sheet
Executive Summary
The clinical utility of a negative test result in the imaging of venous thrombosis will be examined in a post-approval study of Diatide's AcuTect. The apcitide technetium Tc 99m kit was approved by FDA Sept. 14.